Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD)

Kidney International

Volumn 64, Issue 2, 2003, Pages 579-584

  Zoccali, Carmine ^a   Mallamaci, Francesca ^b   Tripepi, Giovanni ^b   Parlongo, Saverio ^b   Cutrupi, Sebastiano ^b   Benedetto, Frank Antonio ^b   Bonanno, Grazia ^b   Seminara, Giuseppe ^b   Fatuzzo, Pasquale ^b   Rapisarda, Francesco ^b   Malatino, Lorenzo Salvatore ^b  

^a CNR   (Italy)

^b NONE

Author keywords

Cardiovascular risk; Chlamydia; Dialysis; ESRD; Survival; uremia

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEROLOGY; SMOKING; SURVIVAL RATE;

EID: 10744227505     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00095.x     Document Type: Article

References (25)

1. LEVEY AS: Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start? Am J Kidney Dis 32(Suppl 3):S5-S13, 1998
2. BAIGENT C, BURBURY K, WHEELER D: Premature cardiovascular disease in chronic renal failure. Lancet 356:147-152, 2000
3. ZIMMERMANN J, HERRLINGER S, PRUY A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
4. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
5. ZOCCALI C, BENEDETTO FA, MALLAMACI F, et al: Inflammation is associated with carotid atherosclerosis in dialysis patients. J Hypertens 18:1207-1213, 2000
6. YEUN JY, LEVINE RA, MANTADILOK V, KAYSEN GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
7. KAYSEN GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 12:1549-1557, 2001
8. STENVINKEL P, HEIMBURGER O, JOGESTRAND T, et al: Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? Kidney Int 55:2531-2532, 1999
9. ZOCCALI C AND THE CREED INVESTIGATORS: C-reactive protein and atherosclerosis in dialysis patients. Nephrol Dial Transplant 13: 2710-2711, 1998
10. HAUBITZ M, BRUNKHORST R: C-reactive protein and chronic Chlamydia pneumoniae infection-long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16:809-815, 2001
11. FOLEY RN, PARFREY PS, HARNETT JD, et al: The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis 28:53-61, 1996
12. BLOCK GA, HULBERT-SHEARON TE, LEVIN NW, PORT FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607-617, 1998
13. MOUSTAPHA A, NASO A, NAHLAWI M, et al: Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97:138-141, 1998
14. MALLAMACI F, ZOCCALI C, TRIPEPI G, et al: The CREED Investigators: Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61:609-614, 2002
15. KIMMEL PL, PHILLIPS TM, SIMMENS SJ, et al: Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244, 1998
16. DANESH J, COLLINS R, PETO R: Chronic infections and coronary heart disease: Is there a link? Lancet 350:430-436, 1997
17. KATO A, ODAMAKI M, TAKITA T, et al: Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 61:1143-1152, 2002
18. STENVINKEL P, HEIMBURGER O, JOGESTRAND T: Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39:274-282, 2002
19. SONG H, TASAKI H, YASHIRO A, et al: Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure. Clin Nephrol 56:346-352, 2001
20. OH J, WUNSCH R, TURZER M, et al: Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105, 2002
21. SAIKKU P, LEINONEN M, TENKANEN L, et al: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116:273-278, 1992
22. WEST R: Commentary: Adjustment for potential confounders may have been taken too far. Br Med J 321:213, 2000
23. DANESH J, WHINCUP P, WALKER M, et al: Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis. Br Med J 321:208-213, 2000
24. WALD NJ, LAW MR, MORRIS JK, et al: Chlamydia pneumoniae infection and mortality from ischaemic heart disease: Large prospective study. Br Med J 321:204-207, 2000
25. DANESH J, YOUNGMAN L, CLARK S, et al: Helicobacter pylori infection and early onset myocardial infarction: Case-control and sibling pairs study. Br Med J 319:1157-1162, 1999